PAB 12.5% 0.5¢ patrys limited

Ann: Full size deoxymab PAT-DX3 crosses the blood brain barrier, page-42

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,710 Posts.
    lightbulb Created with Sketch. 1097
    Chaya,

    Merck will be the first to take interest no doubt...

    But there will be others...a fair bit of Genentech connections on the PAB Board, now owned by Roche.

    Dr Klein was VP Development....Suzy Jones was Head of BD / Partnering...and don't forget where the tech all started - YALE Medical School.

    PAB has more international exposure than most ASX Biotech juniors.

    Big Pharma will be all over this.
    .
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(12.5%)
Mkt cap ! $9.258M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $900 200K

Buyers (Bids)

No. Vol. Price($)
8 20548734 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 7789761 11
View Market Depth
Last trade - 10.49am 11/11/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.